Drug Profile
Tenofovir disoproxil aspartate - Chong Kun Dang
Alternative Names: CKD-390Latest Information Update: 11 Oct 2021
Price :
$50
*
At a glance
- Originator Chong Kun Dang
- Class Antiretrovirals; Antivirals; Phosphonic acids; Purines; Small molecules
- Mechanism of Action Nucleotide reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hepatitis B
Most Recent Events
- 11 Oct 2021 Discontinued - Phase-III for Hepatitis B in South Korea (PO) (Chong Kun Dang Pharmaceutical pipeline, October 2021)